NCT Number: NCT06887699
This trial will prospectively evaluate the impact of integrating AI-ECG within the pay-for-performance program on improving the diagnosis, treatment, and clinical outcomes of occlusion myocardial infarction patients by promoting accurate and timely diagnoses through financial incentives.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Kaohsiung Armed Forces General Hospital, Kaohsiung City, Taiwan
The investigators have developed an AI-ECG system that provides real-time notifications for patients with potential occlusion myocardial infarction. This AI algorithm is seamlessly integrated into the Hospital Information System, allowing for the automatic generation of reports whenever an ECG is performed. The purpose of this study is to evaluate the impact of AI-ECG on the timely diagnosis of STEMI, including patients' outcomes and healthcare costs.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The AI-ECG system will conduct a real-time analysis of the ECG. When the system identifies potential OMI cases, it will immediately send short message service notifications to the on-duty cardiologists. This will enable the cardiologists to promptly review and confirm the diagnosis.
Time frame: From the start of the emergency visit to the following 48 hours.
Door-to-wire time refers to the duration from a patient's arrival at the emergency department (ED) to the successful placement of a wire into the coronary artery during a primary percutaneous coronary intervention (PPCI) procedure.
Time frame: From the start of the emergency visit to 90 days post-discharge.
Total expenditures, from the start of the emergency visit to 90 days post-discharge (in USD), for comparison between the intervention and control groups, based on records from NHI (National Health Insurance) claims data.
Time frame: 48 hours
The proportion of patients achieving a Door-to-Wire time of less than 90 minutes in the intervention group compared to the control group. The intervention and control groups' door-to-wire time will be compared. Door-to-wire time is defined as the duration from the first ECG to the successful placement of the wire during PPCI for OMI patients in the emergent department.
Time frame: 90-day follow
The proportion of patients who die from any cause, regardless of the underlying condition, during hospitalization.
Time frame: 90-day follow
The proportion of patients who die from cardiovascular-related causes during hospitalization.
Time frame: 90-day follow
Comparison of length of ICU between the intervention and control groups.
Time frame: 90-day follow
Comparison of length of hospitalization between the intervention and control groups.
Time frame: 90-day follow
Composite cardiovascular events (Non-fatal MI + Non-fatal stroke + CV Death) The rate of composite cardiovascular events within 90 days.
Time frame: 90-day follow
The rate of non-fatal MI within 90-days.
Time frame: 90-day follow
The rate of non-fatal strokes (both ischemic and hemorrhagic) within 90-days.
Time frame: 90-day follow
The proportion of patients who die from cardiovascular-related causes within 90-days.
Time frame: 90-day follow
The incidence of ischemic stroke.
Time frame: 90-day follow
The incidence of hemorrhagic stroke.
Time frame: 90-day follow
The proportion of patients who die from any cause within 90-days.
Time frame: 90-day follow
The rate of patients who undergo coronary artery bypass surgery (CABG) within 90-days following OMI treatment.
Time frame: 90-day follow
The rate of hospital admissions for heart failure within 90-days following OMI treatment.
Time frame: 90-day follow
The rate of readmission to the hospital within 90-days of discharge.
Time frame: From the start of the emergency visit to the following 48 hours.
The number of patients who received emergent coronary angiograms without lesions need intervention.
Time frame: From the start of the emergency visit to the following 48 hours.
The number of patients who received a procedure with vascular complications.
Time frame: 90-day follow
The number of patients who received a procedure with contrast-induced acute kidney injury.
Time frame: 90-day follow
The proportion of patients who die due to the procedure within 90 days.
Time frame: 90-day follow
The incidence of in-hospital major bleeding events occurring within 90-days of treatment.
Time frame: 90-day follow
The incidence of major bleeding events occurring within 90-days of treatment.
Contact information is provided by the study sponsor or research team.
National Defense Medical Center, Taiwan
Other
A Randomized Clinical Trial Investigating the Impact of Artificial Intelligence Electrocardiography on Occlusion Myocardial Infarction Management Under the Value-Based Payment System
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06847932
Arrhythmias, Cardiac, Artificial Intelligence (AI)
Taipei, Taiwan
View Trial DetailsNCT07441759
Arrhythmias, Cardiac, Artificial Intelligence (AI)
Tortosa, Tarragona, Spain
View Trial DetailsNCT07715617
Alpha-1-antitrypsin Deficiency, Artificial Intelligence (AI)
Bron, France
View Trial DetailsNCT07601373
Artificial Intelligence (AI), Nursing Informatics
Alexandria, Alexandria Governorate, Egypt
View Trial Details